ANZ1001 SORBET: Study of estrogen receptor beta and efficacy of tamoxifen, a single arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer.
Kelly-Anne Phillips
No relevant relationships to disclose
Belinda E. Kiely
No relevant relationships to disclose
Prudence A. Francis
No relevant relationships to disclose
Frances M. Boyle
No relevant relationships to disclose
Stephen B. Fox
No relevant relationships to disclose
Leigh Murphy
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose
Dianne Frances Lindsay
No relevant relationships to disclose
Robert L. Sutherland
No relevant relationships to disclose
Heath D. Badger
No relevant relationships to disclose
John F. Forbes
No relevant relationships to disclose